Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6095 Target Snapshot

DNA (cytosine-5)-methyltransferase 3B · SINGLE PROTEIN · Homo sapiens

126Compounds
49Assays
0Approved Drugs
101.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9UBC3. Use UniProt Q9UBC3 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9UBC3 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA (cytosine-5)-methyltransferase 3B as ChEMBL target CHEMBL6095, mapped to UniProt Q9UBC3. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA (cytosine-5)-methyltransferase 3B
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL6095
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9UBC3
DNA (cytosine-5)-methyltransferase 3B
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA (cytosine-5)-methyltransferase 3B is the right protein anchor across sources, using UniProt Q9UBC3 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA (cytosine-5)-methyltransferase 3B
UniProt AccessionQ9UBC3
Component TypeProtein
Sequence Length853 aa

DNA (cytosine-5)-methyltransferase 3B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA (cytosine-5)-methyltransferase 3B, mapped to UniProt Q9UBC3. Sequence length is 853 aa.

Mapped IDQ9UBC3
Review nameDNA (cytosine-5)-methyltransferase 3B
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5087.0
EC5014.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL418052 6.7 IC50 200.0 Preclinical
CHEMBL555257 6.58 IC50 260.0 Preclinical
CHEMBL5178532 6.52 IC50 300.0 Preclinical
CHEMBL552309 6.52 IC50 300.0 Preclinical
CHEMBL557902 6.52 IC50 300.0 Preclinical
CHEMBL2106789 6.3 IC50 500.0 Clinical
CHEMBL555352 6.22 IC50 600.0 Preclinical
CHEMBL560105 6.22 IC50 600.0 Preclinical
CHEMBL1564869 6.05 IC50 900.0 Preclinical
CHEMBL560505 6.05 IC50 900.0 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
13
5.5
13
6.0
7
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

49
Total Assays
74
Tested Compounds
2
Assay Types
Binding — 48 assays, 74 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 29 22 5.3
cell-based format 17 50 5.3
assay format 2 2 5.7
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine